Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02591316
Other study ID # 2014T34
Secondary ID
Status Completed
Phase N/A
First received October 27, 2015
Last updated July 17, 2016
Start date February 2015
Est. completion date May 2016

Study information

Verified date July 2016
Source Texas State University, San Marcos
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to examine the relationship between nutrition, physical activity and brain function in breast cancer survivors.


Description:

The current study will examine the potential relationships between physical activity, dietary intake, body composition and cognition in breast cancer cancer survivors and age-matched women without a previous cancer diagnosis. Additionally, we will measure blood inflammatory markers to explore the relationship between lifestyle factors and inflammation.

The study involves two, 1hr appointments at Texas State University. The first visit will include cognitive testing and body composition assessment. Participants will be given an activity monitor to wear for one week and a packet of questionnaires to complete at home. At the second visit, a fasted blood sample will be collected, and participants will complete a food frequency questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria:

- Breast cancer survivors must have completed primary treatment (chemotherapy, radiation therapy or both) within past 60 months

- age-matched controls must have no previous cancer diagnosis

- Female

- no history of stroke, heart attack or transient ischemic attack

- not currently pregnant; can speak, read, and write English

- can attend all testing sessions

- not blind or legally blind; nonsmoker

- no current use of computer-based brain training games (e.g. Lumosity ®, BrainHQ ®).

Exclusion Criteria:

- male

- < 30 or > 70 years of age

- breast cancer survivor > 60 months from last treatment or currently undergoing primary treatment

- breast cancer survivor never treated with chemotherapy and/or radiation

- previous cancer diagnosis other than breast cancer

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Intervention

Other:
no intervention


Locations

Country Name City State
United States Texas State University San Marcos Texas

Sponsors (1)

Lead Sponsor Collaborator
Texas State University, San Marcos

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Medical History Self-reported medical history Baseline No
Other Quality of Life Series of questionnaires assessing various aspects of quality of life including physical and mental health Baseline No
Primary Cognition A series of computer-based cognitive tasks will be administered via the NIH Toolbox Cognition Battery Baseline No
Secondary Physical Activity Physical activity will be measured by a waist-worn accelerometer Baseline No
Secondary Diet Quality Diet will be assessed by completion of the online-administered 2005 Block Food Frequency Questionnaire Baseline No
Secondary Body Composition (objectively measured) Body composition will be evaluated by BOD POD assessment Baseline No
Secondary Inflammatory Markers A fasted blood sample will be collected for measurement of inflammatory markers Baseline No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A